Enzymit

The New Chemistry of Enzyme Design

Israel · $15.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$15.0M
Last Round
$5.0M SeedSep 2024
Rounds
3

About

Enzymit designs novel enzymes for cell-free biomanufacturing, producing chemicals faster and more sustainably than traditional methods.

Summary

Enzymit is a Biotech company based in Israel. It has raised $15.0M in total across 3 rounds, most recently a $5.0M Seed round in Sep 2024. Investors include Grove Ventures, Khosla Ventures and First Star Ventures.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ASep 2024
$10.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies